PL365895A1 - Krystaliczna zasada wenlafaksyny i nowe formy polimorficzne chlorowodorku wenlafaksyny oraz sposobyich wytwarzania - Google Patents

Krystaliczna zasada wenlafaksyny i nowe formy polimorficzne chlorowodorku wenlafaksyny oraz sposobyich wytwarzania

Info

Publication number
PL365895A1
PL365895A1 PL01365895A PL36589501A PL365895A1 PL 365895 A1 PL365895 A1 PL 365895A1 PL 01365895 A PL01365895 A PL 01365895A PL 36589501 A PL36589501 A PL 36589501A PL 365895 A1 PL365895 A1 PL 365895A1
Authority
PL
Poland
Prior art keywords
venlafaxine
preparing
processes
crystalline
base
Prior art date
Application number
PL01365895A
Other languages
English (en)
Inventor
Ben-Zion Dolitzky
Judith Aronhime
Shlomit Wizel
Gennady Nisnevish
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL365895(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL365895A1 publication Critical patent/PL365895A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01365895A 2000-10-19 2001-10-19 Krystaliczna zasada wenlafaksyny i nowe formy polimorficzne chlorowodorku wenlafaksyny oraz sposobyich wytwarzania PL365895A1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21

Publications (1)

Publication Number Publication Date
PL365895A1 true PL365895A1 (pl) 2005-01-10

Family

ID=27500045

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365895A PL365895A1 (pl) 2000-10-19 2001-10-19 Krystaliczna zasada wenlafaksyny i nowe formy polimorficzne chlorowodorku wenlafaksyny oraz sposobyich wytwarzania

Country Status (20)

Country Link
US (1) US20020143211A1 (pl)
EP (1) EP1334082A4 (pl)
JP (2) JP2004530638A (pl)
KR (1) KR20030059206A (pl)
CN (1) CN1620420A (pl)
AU (1) AU2002241764A1 (pl)
CA (1) CA2426158A1 (pl)
CZ (1) CZ20031298A3 (pl)
DE (1) DE01988460T1 (pl)
ES (1) ES2206082T1 (pl)
HR (1) HRP20030392A2 (pl)
HU (1) HUP0303496A3 (pl)
IL (2) IL155400A0 (pl)
IS (1) IS6789A (pl)
MX (1) MXPA03003459A (pl)
NO (1) NO20031743L (pl)
PL (1) PL365895A1 (pl)
SK (1) SK5762003A3 (pl)
WO (1) WO2002045658A2 (pl)
YU (1) YU30203A (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US6906087B2 (en) * 2000-10-31 2005-06-14 Ciba Specialty Chemicals Corpation Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
KR20050044673A (ko) * 2001-12-05 2005-05-12 와이어쓰 벤라팍신 하이드로클로라이드의 신규한 결정 다형체 및이의 제조방법
AU2002247945A1 (en) * 2001-12-13 2003-06-23 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
WO2003082806A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Venlafaxine base
WO2003082805A1 (en) 2002-03-28 2003-10-09 Synthon B.V. Low water-soluble venlafaxine salts
AR039163A1 (es) 2002-03-28 2005-02-09 Synthon Bv Besilato de venlafaxina
DE10359154A1 (de) * 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006043577A1 (ja) * 2004-10-20 2006-04-27 Mitsubishi Pharma Corporation フェニルエタノールアミン化合物の製造方法及びその中間体
EP1824815A2 (en) * 2005-10-19 2007-08-29 Teva Pharmaceutical Industries Ltd. Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl) ethyl]cyclohexanol hydrochloride
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
ATE446946T1 (de) 2006-06-27 2009-11-15 Sandoz Ag Neues verfahren zur salzherstellung
EP2081885A2 (en) * 2006-07-14 2009-07-29 Medichem, S.A. Improved processes for preparing venlafaxine base and salts thereof
PT2621891T (pt) * 2010-10-01 2020-02-04 Shan Dong Luye Pharm Co Ltd Polimorfos de cloridrato de 4-metilbenzoato de 4-[2- dimetilamino-1-(1-hidroxiciclohexil)etil]fenilo, métodos para a preparação dos mesmos e utilização dos mesmos
EP3578546A1 (en) 2013-11-15 2019-12-11 Akebia Therapeutics Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (pl) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US6906087B2 (en) * 2000-10-31 2005-06-14 Ciba Specialty Chemicals Corpation Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) * 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
IL196287A0 (en) 2011-08-01
WO2002045658A2 (en) 2002-06-13
CZ20031298A3 (cs) 2003-10-15
IL155400A0 (en) 2003-11-23
NO20031743D0 (no) 2003-04-15
HUP0303496A3 (en) 2005-08-29
WO2002045658A3 (en) 2003-01-16
KR20030059206A (ko) 2003-07-07
DE01988460T1 (de) 2004-04-22
ES2206082T1 (es) 2004-05-16
SK5762003A3 (en) 2003-11-04
YU30203A (sh) 2006-08-17
CN1620420A (zh) 2005-05-25
HUP0303496A2 (hu) 2004-01-28
AU2002241764A1 (en) 2002-06-18
HRP20030392A2 (en) 2005-04-30
CA2426158A1 (en) 2002-06-13
US20020143211A1 (en) 2002-10-03
MXPA03003459A (es) 2005-04-29
EP1334082A2 (en) 2003-08-13
JP2004530638A (ja) 2004-10-07
IS6789A (is) 2003-04-15
EP1334082A4 (en) 2006-02-01
JP2008239629A (ja) 2008-10-09
NO20031743L (no) 2003-06-18

Similar Documents

Publication Publication Date Title
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
EP1463711A4 (en) "NEW POLYMORPH OF SERTRALINE HYDROCHLORIDE AND COMPOSITION CONTAINING THEREOF, NEW METHODS OF PREPARING SERTRALINE HYDROCHLORIDE POLYMORPHES AND AMORPH FORM"
IL149050A0 (en) Polymorphic forms of sertraline hydrochloride
AP2004002989A0 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
HUP0700037A2 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
HUP0501066A2 (en) Process for preparing 4-aminodiphenylamine
HRP20030900A2 (en) Polymorphs of fexofenadine hydrochloride
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
EP1406855A4 (en) NOVEL PROCESS FOR THE PREPARATION OF RAC-BICALUTAMIDE AND INTERMEDIATE PRODUCTS THEREOF
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
PL2181982T3 (pl) Sposób wytwarzania chlorowodorku wenlafaksyny w formie I
EP1295864A4 (en) PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES
EP1242362A4 (en) METHOD FOR PRODUCING FLUOXETINE HYDROCHLORIDE
PL372137A1 (pl) Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny
HUP0302144A3 (en) Process of preparation of aliphatic amines
PL376832A1 (pl) Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny
AU2002308095A1 (en) Process for preparing sertraline hydrochloride polymorphic form ii
AU2003244886A1 (en) Process for preparing tramadol hydrochloride and/or tramadol momohydrate
AU2002347399A1 (en) Venlafaxine hydrochloride polymorphs
CZ20011502A3 (cs) Způsob výroby antidiabetika

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)